Chromosome 6 is one of the largest human chromosomes, making up about 6% of your total DNA, and it carries an outsized influence on health compared with many of its neighbors. Its finished sequence spans roughly 167 million base pairs and contains over 1,500 known genes, many of which play central roles in immune defense, brain development, metabolism, and cancer biology.1PubMed. The DNA sequence and analysis of human chromosome 6 What makes chromosome 6 stand out is the density of medically significant genes packed into relatively small stretches, particularly a region on its short arm that acts as the headquarters of the human immune system.
The Immune System’s Command Center
The single most studied region of chromosome 6 is the major histocompatibility complex, or MHC, located on the short arm. This stretch of DNA encodes the human leukocyte antigen (HLA) system, a set of cell-surface proteins that allow your immune cells to distinguish your own tissues from foreign invaders like bacteria, viruses, and transplanted organs. The MHC carries the largest number of replicated disease associations anywhere in the human genome, spanning autoimmune disorders, cancers, and infectious diseases.2PubMed Central. Interrogating the major histocompatibility complex with high-throughput genomics Despite decades of research, the functional mechanisms behind many of those associations remain poorly understood.
HLA genes are among the most variable in the entire genome. That extreme diversity is a feature, not a bug: it allows the human population as a whole to recognize a vast range of pathogens. But the same variability means that certain HLA combinations can tilt the immune system toward attacking the body’s own tissues, raising the risk of autoimmune disease. The genes in this region show strong linkage disequilibrium, meaning that specific alleles tend to travel together as haplotypes, and those haplotypes often carry risk variants for multiple conditions simultaneously.3PubMed. Exploring the HLA complex in autoimmunity: From the risk haplotypes to the modulation of expression
Autoimmune Diseases Linked to Chromosome 6
The HLA region has been tied to more than a hundred different diseases, including autoimmune conditions, cancers, and susceptibility to infections.4Journal of Bio-X Research. The human leukocyte antigen and genetic susceptibility in human diseases On the autoimmune side, some of the best-known connections include rheumatoid arthritis, type 1 diabetes, Graves’ disease, and multiple sclerosis. Specific HLA class II haplotypes involving the HLA-DRB1, DQA1, and DQB1 genes have been consistently linked to these conditions. Researchers have also found that HLA class I genes, particularly HLA-B and HLA-C, carry independent risk signals for type 1 diabetes, multiple sclerosis, and Graves’ disease, beyond what the class II associations explain.5PubMed Central. The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action
Having a risk-associated HLA haplotype does not guarantee you will develop an autoimmune disease. Environmental triggers, other genes scattered across the rest of the genome, and even gene-expression regulation within the HLA region itself all play a part. Genome-wide studies have identified variants in both coding regions and nearby regulatory sequences that may influence how much of a given HLA protein your cells produce, which in turn can shift the risk up or down.3PubMed. Exploring the HLA complex in autoimmunity: From the risk haplotypes to the modulation of expression That interplay between which version of an HLA gene you carry and how much of it is actually expressed adds a layer of complexity that researchers are still unraveling.
Hereditary Hemochromatosis and Iron Metabolism
Just outside the classical HLA genes, still on the short arm of chromosome 6 at position 6p21.3, sits the HFE gene. Mutations in HFE cause hereditary hemochromatosis, a condition in which the body absorbs too much iron from food. Over time, the excess iron deposits in the liver, heart, pancreas, joints, and pituitary gland, potentially causing organ damage if left untreated. Two specific variants of HFE, known as C282Y and H63D, account for the vast majority of cases.6PubMed. HFE gene and hereditary hemochromatosis: a HuGE review
Hemochromatosis is one of the most common inherited metabolic disorders in people of Northern European descent. Because it is autosomal recessive, you need two copies of the mutant gene to develop full-blown disease. Many people carry one copy without ever knowing it. The condition is treatable once detected, usually through regular blood draws to reduce iron stores, which is why early genetic screening can be genuinely useful in families with a known history.
Neurological Conditions on Chromosome 6
Early-Onset Parkinson’s Disease
The PARK2 (parkin) gene on chromosome 6 is the most frequently mutated gene in early-onset Parkinson’s disease. In one study of families with early-onset disease, about half carried parkin mutations, and among patients whose symptoms started before age 20, the proportion was even higher, reaching 77%. Patients with parkin mutations tended to develop symptoms earlier, were more likely to have symmetric motor involvement and dystonia at onset, and generally responded well to levodopa therapy, though they also had a higher chance of developing involuntary movements as a side effect of treatment.7PubMed. Association between early-onset Parkinson’s disease and mutations in the parkin gene Parkin-related Parkinson’s tends to progress more slowly than the typical late-onset form, so identifying a parkin mutation can help set realistic expectations for a patient’s long-term outlook.
Lafora Disease
A rarer but devastating neurological disorder linked to chromosome 6 is Lafora disease, a form of progressive myoclonus epilepsy. It usually appears in adolescence and involves worsening seizures, rapid cognitive decline, and the formation of abnormal starch-like deposits called Lafora bodies inside neurons. The disease is invariably fatal, typically within a decade of onset.8PubMed. Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice Two genes on chromosome 6, EPM2A on the long arm and NHLRC1 (also called EPM2B) on the short arm, are the primary known causes. The EPM2A gene encodes a protein called laforin, which functions as a phosphatase with a carbohydrate-binding region, and mutations here disrupt the cell’s ability to manage glycogen properly.9PubMed. Lafora progressive Myoclonus Epilepsy mutation database-EPM2A and NHLRC1 (EPM2B) genes
Research into laforin has revealed that the EPM2A gene produces at least two protein versions through alternative splicing. One form is active as an enzyme, while the other can suppress that activity, acting as a natural brake. Mutations that upset the balance between these two forms may contribute to disease.10PubMed. Modulation of functional properties of laforin phosphatase by alternative splicing reveals a novel mechanism for the EPM2A gene in Lafora progressive myoclonus epilepsy Evidence also points to the existence of at least one additional Lafora disease gene that has not yet been identified.
Dyslexia Susceptibility
Chromosome 6 also harbors genes implicated in reading and language development. A region on the short arm at 6p22 contains KIAA0319 and DCDC2, two genes that have been repeatedly linked to developmental dyslexia.11PubMed Central. Strong evidence that KIAA0319 on chromosome 6p is a susceptibility gene for developmental dyslexia Both genes appear to play roles during brain development, particularly in neuronal migration, the process by which newly formed neurons travel to their correct positions in the developing cortex. Animal studies have shown that interfering with KIAA0319 during embryonic development disrupts this migration, leads to structural brain abnormalities, and produces deficits in rapid auditory processing and spatial learning.12PubMed Central. Neocortical disruption and behavioral impairments in rats following in utero RNAi of candidate dyslexia risk gene Kiaa0319
Independent studies in human populations have confirmed that variants in both KIAA0319 and DCDC2 contribute to reading-related traits in the general population, not just in diagnosed dyslexics.13PubMed Central. DCDC2, KIAA0319 and CMIP are associated with reading-related traits Dyslexia is not caused by a single gene, and these chromosome 6 variants are among many scattered across the genome, but the convergence of multiple susceptibility genes in one small chromosomal region is striking.
Metabolic and Endocrine Conditions
Congenital Adrenal Hyperplasia
The CYP21A2 gene on chromosome 6 encodes the enzyme steroid 21-hydroxylase, which is essential for producing cortisol and aldosterone in the adrenal glands. Mutations in CYP21A2 cause congenital adrenal hyperplasia (CAH), one of the most common inherited metabolic conditions. Deficiency of this single enzyme accounts for over 95% of all CAH cases.14PubMed. Congenital Adrenal Hyperplasia (CAH) due to 21-Hydroxylase Deficiency: A Comprehensive Focus on 233 Pathogenic Variants of CYP21A2 Gene In severe forms, the condition can cause life-threatening salt-wasting crises in newborns. Milder, nonclassical forms produce excess androgens, leading to symptoms like early pubic hair, acne, and menstrual irregularities that may not be recognized until later in life.15Balkan Journal of Medical Genetics. A p.P30L Mutation at the CYP21A2 Gene in Macedonian Patients with Nonclassical Congenital Adrenal Hyperplasia Newborn screening programs in many countries now test for CAH, allowing treatment to begin before dangerous complications develop.
Transient Neonatal Diabetes
Chromosome 6 is also home to a striking example of genomic imprinting, where it matters which parent a gene copy came from. Transient neonatal diabetes mellitus (TNDM) is a rare condition, occurring in roughly 1 in 400,000 births, in which newborns develop insulin-requiring diabetes that resolves on its own within months. About one in five cases is caused by paternal uniparental disomy of chromosome 6, meaning the infant inherits both copies of chromosome 6 from the father and none from the mother.16PubMed. Paternal uniparental disomy of chromosome 6 and transient neonatal diabetes mellitus Other cases are linked to duplications on the long arm that are also of paternal origin. The implication is that certain genes on chromosome 6 are normally silenced when inherited from the father and active only from the maternal copy; when both copies are paternal, those normally silenced genes are overexpressed.
Identifying paternal uniparental disomy in a newborn with diabetes can be clinically useful: it predicts that the diabetes will be transient rather than permanent and that there is no increased risk of the condition recurring in future pregnancies.17PubMed. Transient neonatal diabetes mellitus in a child with paternal uniparental disomy of chromosome 6
Heart Disease and the LPA Locus
Near the tip of the long arm of chromosome 6, the LPA gene encodes lipoprotein(a), often written Lp(a), a blood lipid particle that is an independent risk factor for coronary artery disease. A large genetic study found that the LPA locus at 6q26-27 had the strongest association with coronary disease out of all loci tested. Two common variants at this locus, rs10455872 and rs3798220, each independently raised the odds of coronary disease, with odds ratios of about 1.7 and 1.9 respectively. Both variants were strongly linked to higher Lp(a) levels, a reduced number of certain structural repeats in the protein, and smaller Lp(a) particle size. When the statistical models accounted for Lp(a) levels, the genetic association with heart disease disappeared, suggesting the risk is driven entirely through the Lp(a) pathway.18PubMed. Genetic variants associated with Lp(a) lipoprotein level and coronary disease
Unlike LDL cholesterol, Lp(a) levels are largely genetically determined and do not respond well to diet or standard cholesterol-lowering drugs. This has made the LPA locus a target for next-generation therapies, including antisense oligonucleotides designed to reduce Lp(a) production directly. If you have a family history of early heart disease and your standard lipid panel looks normal, asking about an Lp(a) test is reasonable, since the risk this particle carries is invisible on a routine blood draw.
Cancer and the MYB Oncogene
The MYB gene on chromosome 6 acts as a master transcriptional regulator, controlling the activity of many downstream genes. When MYB goes wrong, it can drive cancer. The clearest example is adenoid cystic carcinoma (ACC), a rare but aggressive cancer that most often arises in the salivary glands. Activation of MYB through chromosomal translocation, extra gene copies, or hijacking of distant regulatory elements is considered the defining genomic event in ACC.19PubMed Central. ATR is a MYB regulated gene and potential therapeutic target in adenoid cystic carcinoma About half of adenoid cystic carcinomas carry a specific balanced translocation between MYB on chromosome 6 and another gene called NFIB on chromosome 9.20PubMed Central. MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation That translocation fuses the two genes and keeps MYB stuck in the “on” position, fueling tumor growth. Because MYB activation appears to be a driving event rather than a passenger mutation, it has become a therapeutic target, with research exploring ways to block its downstream signaling.
Schizophrenia Susceptibility
Psychiatric genetics is notoriously complex, with most major disorders linked to hundreds of small-effect genetic variants scattered across the genome. Still, chromosome 6 has emerged as one of the more consistently implicated regions for schizophrenia. Linkage studies identified a susceptibility locus on the long arm, around 6q21-q22.3, with excess allele sharing among affected family members, and this signal was replicated in an independent sample.21PubMed. Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees A separate study of one of the world’s largest known pedigrees with a high rate of schizophrenia found a strong linkage signal at 6q25, with a LOD score of 6.6, well above the threshold generally considered convincing.22The American Journal of Human Genetics. A Schizophrenia-Susceptibility Locus at 6q25, in One of the World’s Largest Reported Pedigrees
The MHC region on the short arm of chromosome 6 has also shown up in large genome-wide association studies for schizophrenia, raising the intriguing possibility that immune-related genes play a role in the disorder. None of this means that a single chromosome 6 gene “causes” schizophrenia, but the chromosome contributes risk from multiple independent loci.
Sensory and Connective Tissue Conditions
Several genes on chromosome 6 affect structures you might not immediately associate with a single chromosome. MYO6, for instance, encodes a motor protein critical for the structure of hair cells in the inner ear. Mutations can cause both dominant and recessive forms of inherited hearing loss, often progressive, by disrupting the tiny stereocilia that hair cells use to detect sound vibrations.23PubMed Central. Clinical Characteristics and In Vitro Analysis of MYO6 Variants Causing Late-Onset Progressive Hearing Loss
The TACSTD2 gene on chromosome 6 is responsible for gelatinous drop-like corneal dystrophy (GDLD), a condition in which amyloid deposits accumulate on the surface of the cornea, progressively clouding vision. Mutations in this gene have been identified in families across different ethnic backgrounds, and affected individuals often require surgical intervention to restore sight.24PubMed Central. Novel TACSTD2 mutation in gelatinous drop-like corneal dystrophy25PubMed Central. Novel Mutations in TACSTD2 Gene in Families with Gelatinous Drop-like Corneal Dystrophy (GDLD)
Connective tissue is also affected. The COL11A2 gene on chromosome 6 encodes a component of type XI collagen, and mutations have been linked to Stickler syndrome, an inherited disorder that can involve joint hypermobility, skeletal abnormalities, hearing loss, and eye problems.26PubMed. A Stickler syndrome gene is linked to chromosome 6 near the COL11A2 gene Meanwhile, mutations in the desmoplakin (DSP) gene on chromosome 6 disrupt cell-to-cell adhesion in the skin and heart. Affected individuals may develop thickened skin on the palms and soles, woolly or sparse hair, and cardiomyopathy in various combinations.27Acta Dermato-Venereologica. Desmoplakin Mutations with Palmoplantar Keratoderma, Woolly Hair and Cardiomyopathy
Structural Abnormalities of Chromosome 6
Beyond single-gene mutations, large-scale structural changes to chromosome 6 can cause recognizable clinical syndromes. Deletions involving the long arm, known collectively as 6q deletion syndrome, produce a wide range of features depending on which genes are missing. Commonly reported effects include distinctive craniofacial features, brain malformations such as absent corpus callosum or abnormal gyral patterns, seizures, muscle weakness, heart defects, and varying degrees of intellectual disability.28PubMed Central. Clinical and genetic features of 6q deletion syndrome: A literature review and case report Some patients also show features that overlap with Prader-Willi syndrome, including small hands and feet and low muscle tone.29PubMed. Interstitial 6q microdeletion syndrome and epilepsy: a new patient and review of the literature
Ring chromosome 6 is an even rarer structural variant in which both ends of the chromosome are lost and the remaining piece curves into a circle. Growth retardation after birth is the most consistent finding, but a review of cases found a notable tendency toward hydrocephalus, sometimes accompanied by facial differences, eye abnormalities, and seizures. One curious laboratory feature is that ring chromosome 6 tends to disappear in certain cultured cell types, making it tricky to detect depending on which tissue is sampled.30PubMed. Ring chromosome 6 in three fetuses: case reports, literature review, and implications for prenatal diagnosis
Evolutionary Conservation of Chromosome 6 Genes
Part of what makes chromosome 6 so gene-rich is deep evolutionary history. A comparative genomics study spanning 23 of the 26 mammalian orders reconstructed ancestral karyotypes across roughly 320 million years of vertebrate evolution and found that gene-dense chromosomal regions have been maintained by purifying selection over that entire span. Developmentally important genes and their regulatory neighborhoods tend to be preserved as intact blocks, rather than broken up by rearrangements, across distantly related species.31PubMed Central. Evolution of the ancestral mammalian karyotype and syntenic regions For chromosome 6, this means that many of its key gene clusters, including the MHC, predate the origin of mammals, and their physical arrangement has been actively maintained because scrambling them would disrupt the coordinated regulation that the immune system depends on.
That deep conservation also explains why animal models are useful for studying chromosome 6 disorders. The parkin gene, the dyslexia candidate genes, and the Lafora disease genes all have functional counterparts in mice and other model organisms, allowing researchers to study disease mechanisms in ways that are not possible in humans. Gene-editing technologies like CRISPR/Cas9 have begun to be explored as potential treatments for inherited conditions caused by single-gene mutations, which several chromosome 6 disorders are.32PubMed Central. The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Inherited Diseases Conditions like CAH and hereditary hemochromatosis, where the responsible gene and mutation are well characterized, are the kinds of targets that precision-medicine approaches are best suited for, even though clinical applications remain mostly in the research phase.